Comparing the Quality of Life of Terminal Ileitis Patients With Crohn's Disease Treated With Anti-TNF or Surgical Resection

• Status: Withdrawn
• Trial end date: 2018-08-01
• Target enrollment: 0
• Participant gender: All

Summary

Compare the quality of life at 6 months between 2 populations of patients followed for terminal ileitis of Crohn's disease treated with anti-TNF or ileocecal resection.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Lille

Criteria

Inclusion Criteria:

• isolated Crohn's ileitis without history of bowel resection and never previously been treated with anti-TNF

• Men and woman over 18 years

• Patient with social security cover

• reapproved indication during multidisciplinary meeting

• Patient able to receive clear information in written and oral

• Informed consent signed by the patient

Exclusion Criteria:

• Prophylactic treatment of recurrence before endoscopic control at the 6th postoperative month.

• Contraindication to Anti-TNF after the initial lap works.

• The side effects of surgery or anti-TNF are not exclusion criteria.